Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aemetis (AMTX) Research & Development (2016 - 2023)

Aemetis has reported Research & Development over the past 12 years, most recently at $37000.0 for Q4 2023.

  • Quarterly results put Research & Development at $37000.0 for Q4 2023, down 9.76% from a year ago — trailing twelve months through Dec 2023 was $152000.0 (down 15.56% YoY), and the annual figure for FY2023 was $152000.0, down 15.56%.
  • Research & Development for Q4 2023 was $37000.0 at Aemetis, up from $36000.0 in the prior quarter.
  • Over the last five years, Research & Development for AMTX hit a ceiling of $117000.0 in Q1 2020 and a floor of $21000.0 in Q2 2020.
  • Median Research & Development over the past 5 years was $37000.0 (2019), compared with a mean of $41900.0.
  • Biggest five-year swings in Research & Development: skyrocketed 254.55% in 2020 and later crashed 80.34% in 2021.
  • Aemetis' Research & Development stood at $45000.0 in 2019, then fell by 15.56% to $38000.0 in 2020, then plummeted by 42.11% to $22000.0 in 2021, then soared by 86.36% to $41000.0 in 2022, then decreased by 9.76% to $37000.0 in 2023.
  • The last three reported values for Research & Development were $37000.0 (Q4 2023), $36000.0 (Q3 2023), and $37000.0 (Q2 2023) per Business Quant data.